Iovance Biotherapeutics (IOVA) Stock
Iovance Biotherapeutics (IOVA) closed at $7.76 on Nov 13, 2026; its Tenet Score is 52 of 100 against 297 Healthcare peers.
21 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $7.76
- Nov 13, 2026
- Market cap
- $3.6B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 2.08 – 15.37
- low → high · as of close, Nov 13, 2026
- Tenet Score
- 52/100
- Mixed · 297 Healthcare peers
Industry: Drugs
Iovance Biotherapeutics Inc scores 52/100. Mixed. Strongest on financial health, quality is the soft spot versus 297 Healthcare peers. Insufficient inputs: Tenet 52 is built from 3 of 4 pillars, from 55% of its inputs. Growth is left out because no growth rate could be measured.
Tenet Score · vs sector
n=297Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
13F flows & insider trades land here.
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical s…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Relay Therapeutics IncRLAY | 43 | $4.0B |
| Xenon Pharmaceuticals IncXENE | 44 | $4.0B |
| Tarsus Pharmaceuticals IncTARS | 33 | $4.0B |
| Amylyx Pharmaceuticals IncAMLX | 55 | $3.9B |
| Viking Therapeutics IncVKTX | 36 | $3.7B |
| Organon & Co.OGN | 45 | $3.7B |
| Enliven Therapeutics IncELVN | 60 | $3.6B |
| Arcutis Biotherapeutics IncARQT | 42 | $3.6B |
| Supernus Inc.SUPN | 52 | $3.5B |
| Acadia Pharmaceuticals IncACAD | 64 | $3.2B |
Common questions
What sector and industry is Iovance Biotherapeutics in?
Iovance Biotherapeutics is in the Healthcare sector and the Drugs industry.
What is Iovance Biotherapeutics' Tenet Score?
Iovance Biotherapeutics' Tenet Score is 52 out of 100, ranked against 297 Healthcare peers as of Nov 13, 2026.




